Seeking Alpha

John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX® (collagenase clostridium histolyticum)

MALVERN, Pa., Nov. 20, 2024 /PRNewswire/ -- Endo, Inc. (NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including his treatment with ...
Pharmabiz

US FDA approves Auxilium Pharma's Xiaflex for concurrent treatment of up to 2 affected joints in same hand in DC patients

Auxilium Pharmaceuticals, a specialty bio-pharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved a supplemental Biologics Application (sBLA) for Xiaflex ...
Hosted on MSN

Endo, Inc. Shares Positive Data on XIAFLEX Treatment for Peyronie’s Disease

MALVERN, PA — Endo, Inc. (OTCQX: NDOI) revealed new insights from a post hoc data analysis of its Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment of ...
Pharmabiz

BioSpecifics presents additional phase III data from Xiaflex

BioSpecifics Technologies Corp. has presented additional data from the phase III clinical programme of Xiaflex for the treatment of Peyronie's disease. The data was conducted by BioSpecifics’ partner ...